Midgard Science

Labs / ADME, DMPK & toxicology

Aclairo Pharmaceutical Development Group, Inc.

Sterling, VA, United States · aclairo.com

Aclairo Pharmaceutical Development Group, Inc. provides nonclinical development and clinical pharmacology consulting for pharmaceutical and biotech clients. It serves programs in human therapeutics from Sterling, Virginia, with support across drug development strategy, DMPK/TK, toxicology, regulatory writing, and clinical pharmacology.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Cell and Gene Therapy Consulting

    Provides strategic advice, program support, study design, and regulatory writing for cell and gene therapy programs, including viral vectors, gene editing, and cell therapies.

  • Clinical Pharmacology Consulting

    Supports pharmacokinetic, pharmacodynamic, dose selection, exposure-response, drug interaction, and special population assessments for regulatory submissions.

  • Nonclinical DMPK and Toxicokinetics Consulting

    Provides ADME, PK/TK analysis, exposure-toxicity assessment, dose justification, and human dose projection support.

  • Nonclinical Drug Development Operations

    Supports planning, vendor selection, CRO oversight, study monitoring, data review, and reporting for nonclinical studies.

  • Nonclinical Drug Development Strategy

    Provides guidance on overall nonclinical development planning and strategy for drug and biologics programs.

  • Nonclinical Pharmacology

    Advises on nonclinical pharmacology program planning and interpretation to support development decisions.

  • Toxicology Consulting

    Provides toxicology expertise for nonclinical development, study interpretation, and regulatory support.

  • Scientific and Regulatory Writing

    Prepares briefing documents, investigator brochures, expert reports, final study reports, and regulatory submissions.

What they work on

Modalities
Small molecule, Antibody, Bispecific, ADC, Peptide, Oligonucleotide, Viral vector, Cell therapy, Gene editing, LNP / formulation
Assays and studies
ADME, PK, TK, PK/PD, bioanalysis, dose selection, exposure-response, drug interaction, special population assessment, toxicology study monitoring
Therapeutic areas
neurology, immunology, oncology, urology, anti-infectives, genetic disorders, cardiovascular, metabolic disorders, women’s health, rare diseases
Type
CRO
Sites
Sterling, United States
Team
over 350 years of combined drug development experience
Serves
United States, European Union, Australia, New Zealand, United Kingdom, China, Japan
Address
45600 Terminal Drive Sterling, VA 20166
Founded
2004

Similar labs. Genevoyager, Aurigene Pharmaceutical Services, Crystal NAX, Esco Aster

Found in a contract services directory. Listing built from aclairo.com. Work here? Claim this listing.

Aclairo Pharmaceutical Development Group, Inc. · Midgard Science